Name | N-(3-aminopropyl)-N-[(1R)-1-(3-anilino-7-chloro-4-oxoquinazolin-2-yl)but-3-ynyl]-3-chloro-2-fluorobenzamide |
---|---|
Synonyms |
Benzamide, N-(3-aminopropyl)-3-chloro-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylamino)-2-quinazolinyl]-3-butyn-1-yl]-2-fluoro-
N-(3-amino-propyl)-3-chloro-N-[(R)-1-(7-chloro-4-oxo-3-phenylamino-3,4-dihydro-quinazolin-2-yl)-but-3-ynyl]-2-fluoro-benzamide ARQ-621 (R)-N-(3-aminopropyl)-3-chloro-N-(1-(7-chloro-4-oxo-3-(phenylamino)-3,4-dihydroquinazolin-2-yl)but-3-ynyl)-2-fluorobenzamide N-(3-Aminopropyl)-N-[(1R)-1-(3-anilino-7-chloro-4-oxo-3,4-dihydro-2-quinazolinyl)-3-butyn-1-yl]-3-chloro-2-fluorobenzamide ARQ 621 |
Description | ARQ 621 is an allosteric, potent and selective inhibitor of Eg5, a microtubule-based ATPase motor protein involved in cell division. Anti-tumor activity[1]. ARQ 621 is a kinesin inhibitor[2]. |
---|---|
Related Catalog | |
Target |
Eg5 |
In Vitro | Over-expression of Eg5 causes genomic instability and tumor formation in mice; therefore, Eg5 is a potential anti-cancer target[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 730.6±70.0 °C at 760 mmHg |
Molecular Formula | C28H24Cl2FN5O2 |
Molecular Weight | 552.427 |
Flash Point | 395.7±35.7 °C |
Exact Mass | 551.129089 |
PSA | 93.25000 |
LogP | 4.18 |
Vapour Pressure | 0.0±2.4 mmHg at 25°C |
Index of Refraction | 1.638 |
Storage condition | -20℃ |